Search

Job

Term of Reference for Senior Pharmaceutical Scientist Consultancy

New
|
Published 25 days ago

Background

The International Treatment Preparedness Coalition (ITPC) is a global coalition of PLHIV and community activists working to achieve universal access to optimal HIV, HCV and TB treatment of those in need. Formed in 2003 by a group of 125 HIV activists from 65 countries at a meeting in Cape Town, ITPC actively advocates for treatment access in eight regions across the globe. ITPC believes that the fight for treatment remains one of the most significant global social justice issues. 

The project ‘Use of TRIPS Flexibilities to Increase Affordability of Treatment for HIV, Tuberculosis and Hepatitis C Virus in Middle-income Countries’ aims to address a critical gap in the global HIV response: access in some LMICs and in UMICs to newer, optimized antiretrovirals (ARVs) for preventing and treating HIV. Access to newer medicines that can cure tuberculosis (TB) and hepatitis C virus (HCV), two common, dangerous coinfections, among people living with HIV, is also necessary. Optimized ARVs are essential to reaching global HIV treatment targets, enacting the WHO ‘treat all’ recommendation and addressing the growing threat of resistance to non-nucleoside reverse transcriptase inhibitors (NNRTIs), which are widely used in first-line treatment. Considering ongoing COVID-19 pandemic ensuring affordability of potential COVID-19 treatments in middle-income countries is an important component of global response.

The use of TRIPS flexibilities, as recommended by the UN High Level Panel on Access to Medicines,[1] will be necessary to improve access to optimized ARVs, TB medicines and DAAs in some LMICs and UMICs. The combined use of different flexibilities by multiple partners can act in synergy. Patent oppositions have proven to be an effective strategy to enable cost savings and put more people on treatment. During the past three years, ITPC, in partnership with the Brazilian Interdisciplinary AIDS Association (ABIA), FGEP, 100% Life, and AIDS Access Foundation (AAF) has challenged thirteen patents on key ARVs. These patent oppositions led to cumulative savings of US$472 million.  

In order to file new patent oppositions in the scope of existing project ITPC consortium hubs shall need technical assistance in preparation and cross-check of scientific arguments for patent oppositions. Capacity of local chemists plays crucial role in ability of local CSOs to prepare and file patent oppositions.

Service Provider Scope of Work 

ITPC wishes to engage a Pharmaceutical Scientist consultant, who will conduct patent opposition templates development work.

Consultant upon request from ITPC shall:

1.     Conduct initial prior art search and preparation of scientific arguments for MMA consortium countries (https://makemedicinesaffordable.org/where-we-work/) patent oppositions or invalidation lawsuits by preparation of patent oppositions templates for HIV, HCV, TB and COVID-19 medicines (including vaccines) requested by ITPC;

2.     Cross-check and provide inputs to draft templates prepared by other pharmaceutical scientists;

3.     Meaningfully participate in ITPC regular technical virtual calls of scientific team.

Duration of Consultancy

-        Start date: 24 May 2021

-        End date: 31 August 2022

Minimum Skills & Qualifications

·     Minimum 2 year of relevant experience in developing scientific arguments for patent oppositions

·     Graduate degree in chemistry or pharmacy

·     Postgraduate degree in relevant field is an advantage

·     Fluency in English

·     Experience in collaboration with community-based organizations on patent oppositions work

Method of Selection

Quality and Cost-Based Selection method shall be used to determine the winner. The following selection criteria with relative weight of criteria showed in percentages shall be used for selection for the bidders’ proposals that meet all obligatory qualification/eligibility requirements above and that essentially meet the above scope and deliverables:

  1. Qualifications and experience of the consultant in working on the subjects detailed above (relative weight 20%) – shall be assessed based on CV or description of experience;
  2. Quality of previous work and reports developed by the consultant (relative weight 30%) – shall be assessed based on example(s) of previous written patent oppositions related works/reports done by the candidate consultant;
  3. Previous experience of collaboration with CSOs filing patent oppositions on medicines (20%) – shall be assessed based on CV or description of experience;
  4. Daily rate demanded by the consultant to achieve the work required (relative weight 30%) – shall be assessed based on provided quotation.

Compensation shall be provided in partial payments on a monthly basis for work completed, satisfactory to ITPC’s quality of service, but not more than for 193 days of work. Payment will be made within 30 days upon delivery of the monthly invoice.

[1] Report of the United Nations Secretary-General’s High-Level Panel on Access to Medicines: Promoting innovation and access to health technologies [Online] September 2016 [Cited 2019 August 04] Available from: http://www.unsgaccessmeds.org/final-report/

Background

The International Treatment Preparedness Coalition (ITPC) is a global coalition of PLHIV and community activists working to achieve universal access to optimal HIV, HCV and TB treatment of those in need. Formed in 2003 by a group…

Details at a Glance

  • Time Commitment
    Part Time Schedule
  • Job Type
    Contract
  • Start Date
    May 26, 2021
  • Application Deadline
    May 14, 2021
  • Education
    4-Year Degree Required
  • Professional Level
    Professional

Level of Language Proficiency

English required, additional languages a plus (Spanish, Portuguese, Thai, Russian)

English required, additional languages a plus (Spanish, Portuguese, Thai, Russian)

Location

Remote
Work may be performed anywhere in the world
Associated Location
Unit 48, The Office Fairground Building, Gaborone, None None, Botswana

How to Apply

Instructions to Tenderers

Tender proposal validity should be no less than 60 days counting from t

The closing date of receiving proposals indicated below. 

Tenderers shall have the right to seek written clarifications on any aspect of the tender documents and receive responses from ITPC in good time before the deadline for submission of tenders, not less than 2 days prior to the deadline. 

The starting date of this tender is 23 April 2021. Closing date for receiving proposals is 14 May 2021 23:59 SAST.

Questions should be sent by potential bidders before 12 May 2021 to the same email address as indicated above.

Expected date to inform the successful candidate is 21 May 2021, although this deadline could be extended by ITPC, if needed.

Tender proposals shall be evaluated by ITPC and the outcome of the selection procedure shall be notified to tenderers by email.

To Apply:

Send a Technical and Financial Proposal that should consist of at least the following documents: 

(i)          CV or description of experience;

(ii)         Quote indicating daily rate in USD (in separate file attachment called “Financial Proposal” or in the body of email); 

(iii)       Certificate/excerpt from registry proving right to conduct business, if any; and 

(iv)        example(s) of previous written patent oppositions related works/reports done by the potential consultant.

to dpeeler@itpcglobal.org with the subject line “Pharmaceutical Scientist Consultancy– Application: Individual or Company Name” by 14 May 2020 23:59 SAST.

Instructions to Tenderers

Tender proposal validity should be no less than 60 days counting from t

The closing date of receiving proposals indicated below. 

Tenderers shall have…

Join Idealist

Sign up today to save your favorite jobs and get email alerts when new ones are posted.